Concepedia

Christopher B. Benton

CB

30

Publications

2K

Citations

21

H-Index

1997

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

University of California, Irvine

Washington University in St. Louis

Baylor College of Medicine

Christopher B. Benton is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematology.

ORCID

Top concepts

Publications per year

1997–2024

30

Publications

30

Clinical experience with the <scp>BCL</scp>2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies

Courtney D. DiNardo, Caitlin R. Rausch, Christopher B. Benton et al. · American Journal of Hematology · 2017 · 429 citations · Full text

The crystal structure of human interferon β at 2.2-Å resolution

Michael Karpusas, M. Chester Nolte, Christopher B. Benton et al. · Proceedings of the National Academy of Sciences · 1997 · 206 citations

Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study

Farhad Ravandi, Rita Assi, Naval Daver et al. · The Lancet Haematology · 2019 · 137 citations · Full text

, , +9

Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes

Guillermo Montalban‐Bravo, Rashmi Kanagal‐Shamanna, Christopher B. Benton et al. · Blood Advances · 2020 · 125 citations · Full text

, , +17

Malignancy‐associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes

Hagop M. Kantarjian, Jing Ning, Preetesh Jain et al. · Cancer · 2016 · 120 citations · Full text

Rows per page

1–5 of 30